Immune memory cells in ovarian cancer produce tumor-targeting antibodies, opening a vaccine path

While we tend to quickly forget having been ill or having received a vaccine, the immune system remembers remarkably well. It ...
Fierce Biotech

OSE turns up the heat on ovarian cancer with phase 2, Keytruda-supported win

OSE Immunotherapeutics has shared phase 2 data on its neo-epitope vaccine candidate and Keytruda in ovarian cancer, linking ...
Healio

Short-term fasting linked to better outcomes among women with advanced ovarian cancer

Fasting before and after chemotherapy may improve treatment response among women with high-grade serous ovarian cancer, ...

New treatment offers hope for endometrial cancer patients

The TroFuse-005 trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum ...

Ovarian cancer cells use stress hormone signaling to shut down immune system, research reveals

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...
TMCnet

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer Topline results to be presented by Alexandra Leary, MD, PhD, on May 30, 2026, ...
Science Daily

New bacterial therapy destroys cancer without the immune system

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune ...